Skip to content

Ketamine assisted psychotherapy to reduce chronic neuropathic pain: A mixed-methods randomized pilot trial.

Med August 13, 2026 DOI: 10.1016/j.medj.2026.101259 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Mixed-methods randomized pilot trial Pilot study Peer reviewed
Interventions Ketamine-assisted psychotherapy Ketamine
Topics Esketamine Ketamine Psychedelic-assisted therapy
Key findings Ketamine-assisted psychotherapy was feasible and acceptable for chronic neuropathic pain, with both groups experiencing reduced pain intensity and improved mood; qualitative findings suggest psychotherapy may add psychological benefits, but the pilot nature and small sample warrant larger trials.

Abstract

Ketamine assisted psychotherapy to reduce chronic neuropathic pain: A mixed-methods randomized pilot trial.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

  • Ketamine-assisted psychotherapy was feasible and acceptable for chronic neuropathic pain, with both groups experiencing reduced pain intensity and improved mood; qualitative findings suggested psychotherapy may add psychological benefits.

    Synthesized

Comparable studies

Other randomized controlled trials on ketamine and psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. Detoxified heroin-addicted patients 2002 Randomized controlled trial n = 70
Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence Detoxified inpatients with heroin dependence 2007 Randomized controlled trial n = 59
Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: Protocol for a Pilot Randomized Controlled Trial. Patients with chronic neuropathic pain at the Chronic Pain Clinic, St. Michael's... 2024 Pilot randomized controlled trial n = 30
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence Participants with post-traumatic stress disorder (PTSD) 2021 Randomized clinical trial n = 21

Explore topics

By condition and practice